Skip to Content
 

News: Translational Research and Interventional Oncology Research Program

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Friday, February 5th, 2021

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

VUMC, Case Western apply artificial intelligence to “customize” oral cancer treatment

Tuesday, January 5th, 2021

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients.

Rini to lead NCI study of COVID-19 in cancer patients

Thursday, October 29th, 2020

Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

Lovly to chair foundation’s scientific leadership board

Thursday, October 29th, 2020

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).

Grant bolsters Weiss’ pediatric thyroid cancer research

Thursday, November 7th, 2019

Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.

Study identifies targeted therapy’s cardiac risks

Thursday, October 3rd, 2019

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

New prostate cancer treatment concept

Friday, August 30th, 2019

Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

Grant bolsters research on myelodysplastic syndromes

Friday, August 9th, 2019

Michael Savona, MD, professor of Medicine and Cancer Biology, and director of Hematology Research at Vanderbilt-Ingram Cancer Center, has received a competitive grant award from the Edward P. Evans Foundation.

Encephalitis identified as rare toxicity of immunotherapy treatment

Monday, July 22nd, 2019

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

Childhood cancer: how it’s different than for adults

Saturday, June 29th, 2019

The nature of childhood cancer is different than adult cancer, and so is the approach to treatment.

Next Page »